Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines
about
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth.The Antineoplastic Effect of Nitric Oxide-Donating Acetylsalicylic Acid (NO-ASA) in Chronic Lymphocytic Leukemia (CLL) Cells is Highly Dependent on its Positional Isomerism.NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models.Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation.Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review.Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma.Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity.Designing protease sensors for real-time imaging of trypsin activation in pancreatic cancer cells.Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionalityStudy of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines.
P2860
Q36495493-9F83895F-F049-4594-A282-E53D4B709C74Q36602038-C153E0F8-FEE3-478D-A919-D5ED9AB8368BQ36612625-EC93C339-F347-4917-90B5-2B8061833908Q37166556-ABA91290-98DC-49DA-B99E-A5C8106AB415Q37294511-AD46CBFE-8125-45C8-BB76-98E7AF0A5030Q37372211-548FB88C-FE34-46AC-87A7-8A5C9362E792Q38068081-A3EF8DD0-4F0D-411A-8740-BB94ADF5FA06Q38718750-663F3E85-0565-4D87-BF4A-1AF5B1CB5758Q39418780-A96010B3-5C6E-42BF-B1DE-E174107CE9F8Q39875439-88660DDF-9D5A-4699-9B62-959484703722Q39981234-4974CFE6-A342-4DF0-B3FB-FBB6DFAB6266Q40059935-EB641863-A83E-4C77-8F9E-3B1AC24900E8
P2860
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular characterization of ...... n pancreatic cancer cell lines
@ast
Molecular characterization of ...... n pancreatic cancer cell lines
@en
Molecular characterization of ...... n pancreatic cancer cell lines
@nl
type
label
Molecular characterization of ...... n pancreatic cancer cell lines
@ast
Molecular characterization of ...... n pancreatic cancer cell lines
@en
Molecular characterization of ...... n pancreatic cancer cell lines
@nl
prefLabel
Molecular characterization of ...... n pancreatic cancer cell lines
@ast
Molecular characterization of ...... n pancreatic cancer cell lines
@en
Molecular characterization of ...... n pancreatic cancer cell lines
@nl
P2093
P50
P1433
P1476
Molecular characterization of ...... n pancreatic cancer cell lines
@en
P2093
Dino Amadori
Giovanni Brigliadori
Manlio Bolla
Marco Rosetti
Wainer Zoli
P2860
P2888
P304
P356
10.1007/S10495-006-6986-X
P407
P577
2006-08-01T00:00:00Z